Back

ScientiaCME

  • Carcinoma, Squamous Cell
  • Immunosuppression Therapy
  • Keratosis, Actinic

Spotlight on actinic keratosis: updates in practice and treatment optimization

In this online, self-learning activity: Actinic keratosis (AK) is a disorder characterized by precancerous epidermal lesions caused by cumulative sun exposure that may progress to squamous cell carcinoma. It is one of the most common dermatologic diagnosis in U.S. patients, and its prevalence is increasing, with three in ten Medicare patients having a AK-related healthcare visit. AK develops due to excessive radiation exposure from the sun inducing pathologic changes in the epidermal keratinocyte through the disruption of regulatory pathways involved in cell growth and differentiation. Inflammation and immunosuppression lead to the intraepidermal generation of abnormal keratinocytes, which give rise to AKs. Generally, AKs are asymptomatic but some patients may experience local tenderness in addition to the multitude of clinical variants seen upon presentation. The average risk for malignant transformation is 8% in immunocompetent patients, with a range from 0.025% to 16%. However, while the risk of malignant transformation is relatively low, the majority of squamous cell carcinomas stem from AKs.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME · seen on scientiacme.org

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Apr 28, 2024
  • Last day to claim credit
    Apr 29, 2027 7 months left